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Abstract
Antimicrobial peptides (AMPs) are important potential alternatives to conventional therapies against bacterial infections.
rBPI21 is a 21 kDa peptide based on the N-terminal region of the neutrophil bactericidal/permeability-increasing protein (BPI).
This AMP possesses highly selective bactericidal effects on Gram-negative bacteria and have affinity for lipopolysaccharide
(LPS) which is believed to be at the origin of its neutralizing effect of the LPS segregated into the bloodstream. We aim at
understanding the molecular bases of rBPI21 bactericidal and LPS neutralization actions, using biomembrane model systems.
Using dynamic light scattering spectroscopy we demonstrate that rBPI21 promotes aggregation of negatively charged large
unilamellar vesicles (LUV), even in the absence of LPS, and LPS aggregates, while for zwitterionic phosphatidylcholine (POPC)
LUV the size remains unchanged. The peptide also promotes the fusion (or hemifusion) of membranes containing
phosphatidylglycerol (POPG). The aggregation and fusion of negatively charged LUV are peptide concentration-dependent
until massive aggregation is reached, followed by sample flocculation/precipitation. Concomitantly, there is a progressive
change in the zeta-potential of the LUV systems and LPS aggregates. LUV systems composed of phosphatidylglycerol (POPG)
and lipid mixtures with POPG have higher zeta-potential variations than in the absence of POPG. The interaction of rBPI21 with
lipid vesicles is followed by leakage, with higher effect in POPG-containing membranes. LPS aggregation can be related with a
decreased toxicity, possibly by facilitating its clearance by macrophage phagocytosis and/or blocking of LPS specific receptor
recognition. Our data indicate that rBPI21 mechanism of action at the molecular level involves the interaction with the LPS of
the outer membrane of Gram-negative bacteria, followed by internalization and leakage induction through the (hemi)fusion of
the bacterial outer and inner membranes, both enriched in phosphatidylglycerol.
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Introduction
The innate immune system acts as a first line in the defense of
many organisms against pathogens [1]. Antimicrobial peptides
(AMPs) are part of the innate immune system of several organisms
and usually have a broad spectrum of action against pathogens.
During infection they are produced by the cells of the innate immune
system and exert their effects on Gram-negative and Gram-positive
bacteria, as well as on fungi, viruses and parasites [2]. AMPs have
defined properties that ensure selective interaction with microbial
plasma membranes [2–5]. Usually they are hydrophobic and have a
positive net charge. Gram-negative bacteria have two membrane
bilayers, the asymmetric outer membrane, mainly composed of
lipopolysaccharide (LPS) in the outer leaflet and phospholipids in the
inner leaflet, and the inner bilayer, composed by phospholipids [6].
The LPS molecules are very compact due to the salt bridge formed by
the presence of Mg2+ and Ca2+ ions. This maintains an impermeable
barrier to certain antibiotics and contributes to bacterial resistance.
LPS possess three distinct parts in their constitution: 1) a
hydrophobic moiety, also denominated as lipid A (the biological
active part [7]); 2) an oligosaccharide core attached to the lipid A via
ketodeoxyoctonic acid (KDO); and 3) repeating saccharide units with
different sizes depending on the bacterial species [6,7]. During
infection, bacteria release LPS from their membranes into the
bloodstream of the host. Also, the LPS concentration in the
bloodstream increases by the action of some antibiotics [8]. LPS
interacts preferentially with monocytes/macrophages, promoting the
release of several cytokines [9,10]. The overproduction of these
cytokines has harmful pathophysiological effects on the host, such as
septicemia and lethal septic shock. Thus, it is necessary to find new
antibiotics that exert cytotoxic effects and, at the same time, possess
LPS-neutralization properties.
Human neutrophils have many anti-infective components in
their granules. Bactericidal/permeability-increasing protein (BPI)
is a 55-kDa protein located in primary granules of neutrophils
[11,12]. This protein acts selectively against Gram-negative
bacteria where it exerts: 1) cytotoxic effects by membrane damage;
2) neutralization of the lipopolysaccharide endotoxin and; 3)
opsonisation of bacteria, becoming a target to phagocytic cells.
BPI has a boomerang shaped structure composed of two domains
[13,14]: whereas the cationic N-terminal region of BPI has
antibacterial and LPS-neutralizing properties, the anionic C-
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terminal is required for opsonic activity [15,16]. The 21 kDa
recombinant N-terminal fragment of BPI (rBPI21), corresponding
to the first 193 amino acids of BPI (except for the point mutation
C132A [17]), also retains the bactericidal and neutralizing activity
of the BPI [18,19]. This fragment, presently on phase III clinical
trials, was shown to be a promising agent against meningitis and
septic shock [20]. Some studies of the interaction between rBPI21
and membranes have been reported [21–23]. However, previous
studies have not focused on the membrane damage/alteration that
occurs as a consequence of the interaction and its lipid selectivity.
In this paper we aim to address the question how the LPS molecules,
segregated from the bacterial membrane, are neutralized, based on the
in vitro interaction with rBPI21. Another issue is to understand the
selectivity of rBPI21 membrane effects, to unravel the role of phos-
pholipids and LPS on the increase of bacterial permeability.
Methods
Phosphate buffer saline (20 mM sodium phosphate, 150 mM
NaCl) pH 7.4 was used in all the measurements, except when
indicated otherwise.
Large Unilamellar Vesicles and Lipopolysaccharide
Aggregates Preparation
Large unilamellar vesicles (LUV) with ,100 nm of diameter
were obtained by extrusion of multilamellar vesicles, as described
elsewhere [24]. 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(19-sn-glyc-
erol) (POPG) were obtained from Avanti Polar Lipids (Alabaster,
AL), while LPS (Escherichia coli O26:B6) was from Sigma (St. Louis,
MO). The LUV studied were zwitterionic (pure POPC) or anionic
(POPC:LPS 80:20 w:w, POPC:POPG 80:20, POPC:POPG 55:45,
pure POPG and POPC:POPG :LPS 60:20 :20). For lipid film
formation with LPS, the LPS molecules were dissolved in
chloform:methanol (2:1) and the solution was extensively vortexed
and bath sonicated at 40uC during 15 min. Stock solutions of LPS
aggregates were bath sonicated at 40uC during 20 min. The stock
solution was kept at 4uC overnight before measurements.
Dynamic Light Scattering and Zeta-Potential Measurements
of Large Unilamellar Vesicles in the Presence of rBPI21
Dynamic light scattering experiments were carried out on a Malvern
Zetasizer Nano ZS (Malvern, UK) with a backscattering detection at
173u, equipped with a He-Ne laser (l= 632.8 nm), at 37uC, using
disposable polystyrene cells. The LUV suspensions were diluted to
desired final concentration and then filtered using a syringe filter with
0.45 mm pore size (Whatman, Florham Park, NJ). Lipid concentration
was kept constant at 50 mM and the rBPI21 (99% pure, kind gift from
XOMA, Berkeley, CA) concentration varied from 24 nM to 238 nM.
The samples were left equilibrating for 30 min at 37uC. Normalized
intensity autocorrelation functions were analyzed using the CONTIN
method [25,26], yielding a distribution of diffusion coefficients (D). The
measured D is used for the calculation of the hydrodynamic diameter





where k is the Boltzmann constant, T the absolute temperature, and
g the medium viscosity. A set of 15 measurements (,13 runs each) for
the liposomes in the absence and presence of each different rBPI21
concentration were conducted to calculate de DH value. The DH of the
sample was obtained from the peak with the highest scattered light
intensity (i.e., the mode) in light scattering intensity distributions.
The zeta-potential (f) of the liposomes was determined at 37uC
from the mean of 15 measurements (120 runs each), in the absence
and presence of different rBPI21 concentrations, by phase analysis
light scattering (PALS) in the previously indicated apparatus, using
disposable zeta cells with gold electrodes. Values of viscosity and
refractive index were set at 0.8872 cP and 1.330, respectively. Lipid
concentrations were fixed at 200 mM in order to acquire high enough
count rates. The electrophoretic mobility obtained was used for the





where u is the electrophoretic mobility, g the viscosity of the
solvent and e its dielectric constant.
Dynamic Light Scattering and Measurement of
Zeta-Potential of Lipopolysaccharide Aggregates in the
Presence of rBPI21
The LPS aggregates were diluted to 300 mg.mL21 (correspond-
ing to 130 mM, taking into account the molecular weight of 2500
Da of deep rough LPS from Salmonella Re595 [27]) in a syringe
and filtered through Whatman nylon filter with a pore diameter of
0.45 mm (Florham Park, NJ). rBPI21 concentration varied from
0.36 to 11.4 mM. The conditions used above for the LUV were
applied to the measurements with LPS aggregates. A set of 15
measurements (,13 runs each) for the LPS aggregates in the
absence and presence of each different rBPI21 concentration were
conducted to calculate de DH value. For the zeta potential
measurements, the LPS aggregates were diluted in 100 mM Tris/
HCl buffer with 2 mM CsCl, at pH 7.4, which yields more
reproducible values. Zeta-potential was calculated from the mean
of 15 measurements (120 runs each).
LUV Lipid Mixing Assay in the Presence of rBPI21
Peptide-induced lipid mixing in vesicles was measured by Förster
resonance energy transfer (FRET). This assay is based on the
decrease in resonance energy transfer between two membrane
probes, dipalmitoylphosphatidylehtanolamine-sulforhodamine B
(RhB-PE) and 1,2-dihexadecanoyl-sn-glycero-3-phospho[N-4-nitro-
benz-2-oxa-1,3-diazolyl]ethanolamine (NBD-PE), both from Sigma
(St. Louis, MO), when the lipids of the vesicles labeled with both
probes are allowed to mix with lipids from unlabelled vesicles. The
concentration of each of the fluorescent probes within the pre-fusion
liposome membrane was 0.6 mol %. LUV were prepared as
described above. Labeled and unlabeled vesicles in a proportion of
1:4, respectively, were placed in fluorescence cuvette at a total final
lipid concentration of 100 mM, at 25uC, under constant stirring. The
fluorescence was measured using a Varian Cary Eclipse fluorescence
spectrophotometer (Mulgrave, Australia), with excitation at 470 nm
and emission recorded between 500 and 650 nm. Excitation and
emission slits were set to 10 nm. Phospholipid mixing was quantified





where R is the value of the ratio between the fluorescence
intensity with emission at 530 nm and 588 nm, corresponding to
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the maximum fluorescence emission of NBD and RhB, respec-
tively, obtained 10 min after peptide addition to a mixture
containing liposomes having 0.6 mol% of each probe plus
liposomes without any fluorescent probe. R0 is the ratio before
peptide addition (constant during the evaluated time range), and
R100% the ratio after addition of Triton X-100 at a final
concentration of 1% (v/v). For lipid mixing experiment, assays
were conducted in triplicate.
LUV Leakage Assay in the Presence of rBPI21 by
Fluorescence Spectroscopy
Peptide-induced lipid vesicle leakage was also measured by
fluorescence spectroscopy on a Varian Cary Eclipse fluorescence
spectrophotometer (Mulgrave, Australia). In this assay we moni-
tored the release of 5,(6)-carboxyfluorescein (CF), purchased from
Sigma (St. Louis, MO), trapped in LUV. LUV were obtained as
previously described, with the exception that the dried film was
hydrated in 20 mM Tris-HCl with 150 mM NaCl, containing 100
mM CF (the pH was titrated to 7.4 with the addition of NaOH).
Free CF was removed by passing the suspension through an Econo-
Pac 10 DG column from Bio-Rad (Richmond, CA), where the
vesicles are eluted with the void volume. Aliquots of eluted
liposomes were used to determine the amount of phospholipid by
the phosphorus assay [29]. Aliquots of the liposomal stock
preparations (diluted to 10 mM) were incubated with various
concentrations of the rBPI21 to be tested at 25uC, and fluorescence
was recorded continuously for 30 min, under stirring (wavelength of
excitation, lexc = 492 nm; wavelength of emission, lem = 517 nm).
At the end of each experiment, total CF was determined after lysing
the liposomes with 1% Triton X-100. The rates of CF leakage are






where F is the fluorescence intensity measured 20 min after
peptide addition, F0 is the fluorescence intensity measured after 20
min without peptide addition, and F100% is the fluorescence
measured after disruption with Triton X-100. The fluorescence
intensities were corrected for the dilution introduced by the
addition of peptide and Triton X-100. For leakage experiment,
assays were conducted at least in duplicate.
Statistical Analysis
Unpaired Student’s t-test was used for statistical analysis of
intergroup comparison. Differences were considered statistically
significant for p,0.05. Measurement reproducibility analysis
yielded coefficients of variation ,10% for the hydrodynamic
diameter and zeta-potential experiments, and ,1% for the
fluorescence intensity measurements.
Results and Discussion
Dynamic Light Scattering of LPS Aggregates in the
Presence of rBPI21
To investigate the physical changes in the LPS aggregates, their
size alterations in the presence of rBPI21 were studied by dynamic
light scattering. rBPI21 promotes the aggregation of LPS
aggregates in a concentration dependent manner (Figures 1 and
2). In solution, LPS aggregates have a size distribution centered at
84 nm (Figure 1). When peptide is added, larger particles are
formed due to extensive aggregation. The polydispersity of the
samples increases with the size increment. At rBPI21 concentra-
tions above 9 mM, the sample size distribution becomes highly
polydispersed with the onset of two independent populations.
Higher rBPI21 concentrations promote massive aggregation and
precipitation. This massive aggregation can contribute to reduce
LPS toxicity, through the inhibition of the interaction of LPS with
its receptor [30,31] and by facilitating the phagocytosis of the
aggregates by macrophages [32]. However, higher concentrations
of the peptide are needed to promote significant aggregation of
LPS when compared with the concentrations needed to cause
equivalent effects in LUV (see below). The LPS used possesses a
Figure 1. Size distributions of LPS aggregates in the presence
of different concentration of rBPI21.
doi:10.1371/journal.pone.0008385.g001
Figure 2. Aggregation of LPS promoted by rBPI21. Hydrody-
namic diameter variation of LPS aggregates with increasing
rBPI21 concentration. Bars represent the size range from three
independent experiments.
doi:10.1371/journal.pone.0008385.g002
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long chain of the saccharide portion, which hinders the interaction
of the peptide with the negative charges of the LPS, due to the
phosphate groups on lipid A. Thus, a higher peptide concentration
seems to be needed to overcome the barrier created by the
saccharide portion in order to promote aggregation.
Zeta-Potential of LPS Aggregates in the Presence of
rBPI21
In order to evaluate if the peptide interacts with LPS aggregates
by electrostatic forces, a detailed analysis of the interaction
between rBPI21 and LPS was obtained from the electrophoretic
mobility. Figure 3 shows that the LPS aggregates in the absence of
the peptide possess a zeta-potential of 222 mV. Increasing
concentrations of peptide promote the neutralization of the
negative charge and even an overcompensation of the LPS
aggregates charge at higher rBPI21 concentrations, which indicates
an entrapment of the peptide beyond electrostatic equivalence.
Dynamic Light Scattering of Liposomes in the Presence
of rBPI21
To evaluate the perturbation in specific membrane composi-
tions, physical changes in biomembrane model systems promoted
by rBPI21 were assessed by dynamic light scattering. The size
distributions obtained for the LUV show a low polydispersity, with
a 106 nm average hydrodynamic diameter for all lipids and lipid
mixtures, except for pure POPC LUV, which have a 122 nm
average diameter (Figure 4). Upon addition of rBPI21, the
hydrodynamic size of the LUV containing negatively charged
LPS or POPG (bacterial membrane mimetic systems) increases.
These larger entities correspond to the aggregation and/or fusion
of the liposomes caused by the peptide. On the other hand, for
zwitterionic membranes made of POPC (mammalian membrane
mimetic system) the size does not change, even at larger rBPI21
concentrations (Figure 4). At peptide to lipid ratios higher than
0.005, the size of the lipid vesicles containing negatively charged
POPG increases dramatically, leading to lipid vesicle aggregation,
increased turbidity and, finally, precipitation. The peptide effect is
more pronounced on the vesicles with POPG when compared
with POPC and POPC:LPS (80:20). This result can be explained
by the loss of electrostatic attraction by POPC and in POPC:LPS
membranes due to the compact structure of LPS and also by the
size of the saccharide portion, which forms a steric barrier for
aggregation [33]. However, for membranes of POPC with both
POPG and LPS (20% each) the result obtained is not significantly
different of the obtained for membranes composed of POPC and
POPG or pure POPG (Figure 4). Nomura et al. showed that in
membranes composed of negatively charged phospholipids, the
incorporation of deep rough mutant LPS (ReLPS) is severely
reduced [34]. Furthermore, the membrane-incorporated ReLPS
forms LPS or LPS/phospholipid clusters in certain regions of the
membrane. This can result from the electrostatic repulsion
between POPG and ReLPS. The aggregated ReLPS, due to its
compact nature and to the steric obstacle caused by the saccharide
portion, has an impaired interaction with the peptide. Thus, the
peptide may accumulate at the level of the accessible POPG
headgroups and promote the vesicle aggregation/fusion, as occurs
for POPC:POPG mixtures and POPG liposomes. The same result
was also obtained by Allende and McIntosh, by showing that the
addition of bacterial phospholipids to deep rough LPS membranes
increases the susceptibility to melittin [35].
Zeta-Potential of Liposomes in the Presence of rBPI21
In order to analyze the contribution of the electrostatic force in
peptide-biomembrane models interaction, zeta-potential measure-
ments were done with membrane mimetic systems, as previously
described in the Methods section. For POPC:POPG biomem-
brane models with different proportions of POPG (0%, 20%, 45%
and 100%) without the addition of the peptide, lipid vesicles
present zeta-potential values of 25.3 mV, 223.5 mV, 235.2 mV
and 241.1 mV, respectively (Figure 5). For biomembrane models
of POPC:LPS and POPC:POPG :LPS the initial zeta-potential
value are 27.7 mV and 225.2 mV, respectively. Those potentials
Figure 3. Zeta-potential for LPS aggregates in the presence of
rBPI21. Bars represent the zeta-potential range from two independent
experiments.
doi:10.1371/journal.pone.0008385.g003
Figure 4. Aggregation of LUV caused by rBPI21. Hydrodynamic
diameter variation of lipid vesicles with increasing rBPI21 concentration.
Bars represents the size range from three independent experiments.
Larger ranges are intrinsically associated to vesicles flocculation/
precipitation (marked *). POPC (black circles); POPG (blue circles);
POPC:POPG 55:45 (orange circles); POPC:POPG 80:20 (green circles);
POPC:LPS 80:20 (red circles); POPC:POPG:LPS 60:20:20 (brown circles).
The lipid concentration was kept constant at 50 mM. The differences in
hydrodynamic size for [rBPI21]/[Lipid] = 0.0048 were statistically signif-
icant for the following data pairs: POPC/POPC:POPG (80:20), POPC/
POPC:POPG (55:45), POPC/POPG, POPC/POPC:POPG:LPS (60:20:20),
POPC:LPS (80:20)/POPC:POPG (80:20), POPC:LPS (80:20)/POPC:POPG
(55:45), POPC:LPS (80:20)/POPG and POPC:LPS (80:20)/POPC:POPG:LPS
(60:20:20).
doi:10.1371/journal.pone.0008385.g004
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increase toward positive values when the peptide is present, with
different behaviour for the tested membrane mimetic systems.
Zeta-potential can be used as a measure of sample stability. The
general dividing line between stable and unstable suspensions is
generally considered at 630 mV. Particles with zeta-potentials
more positive than +30 mV or more negative than 230 mV are
normally considered stable, whereas the particles with zeta-
potentials between 230 mV and +30 mV have tendency to
flocculate [36]. At the limit peptide to lipid ratio for dynamic light
scattering measurements of 0.005, the zeta-potential of the lipid
vesicles were within the positive instability region, except for
membrane lipid systems composed of POPC:POPG 55:45 and
pure POPG (Figure 5). As a consequence, the aggregation/
flocculation of the systems composed of POPC:POPG or pure
POPG cannot be explained only by the electrostatic interactions.
A bridging phenomenon seems to motivate the aggregation, by the
interaction of the rBPI21 with several liposomes due to high
number of positive amino acids on the peptide [37]. The unfolding
of the peptide when interacting with membranes exposes some of
the positive charges toward the medium, promoting the bridging
between liposomes [21]. At higher peptide to lipid ratios an
overcompensation of the potential is observed. This means that the
peptide not only adsorbs on the surface of the vesicles, neutralizing
its charge, but also inserts on the membrane, due to hydrophobic
interactions [21]. Another aspect that should be referred is the
interaction of the peptide with neutral POPC vesicles, observed by
the zeta-potential measurements, while the size remained
unchanged, as seen by dynamic light scattering. Apparently, the
interaction of the peptide with neutral liposomes is weaker, when
compared to the negatively charge membranes, and must be
limited to the surface of the bilayer, making this interaction
difficult to detect by other methods [21]. rBPI21 interaction with
pure POPC bilayers may be explained by the repulsion of the
positive charged end group of the choline towards the aqueous
phase, due to the high density of the positive amino acids in
rBPI21, exposing the hydrophobic region of the lipid for the
interaction with the peptide [38,39]. Despite the lower aggregation
state of the POPC:LPS in the presence of rBPI21, the peptide is
Figure 5. Zeta-potential for membrane model systems in the
presence of rBPI21. Bars represent the zeta-potential range from at
least two independent experiments. POPC (black circles); POPG (blue
circles); POPC:POPG 55:45 (orange circles); POPC:POPG 80:20 (green
circles); POPC:LPS 80:20 (red circles); POPC:POPG:LPS 60:20:20 (brown
circles). The lipid concentration was kept constant at 200 mM. The
differences in potential-zeta for [rBPI21]/[Lipid] = 0.015 were statistically
significant for the following data pairs: POPC/POPC:LPS (80:20), POPC/
POPC:POPG (80:20), POPC/POPC:POPG (55:45), POPC/POPG, POPC/
POPC:POPG:LPS (60:20:20), POPC:LPS (80:20)/POPG; POPC:POPG
(80:20)/POPG, POPC:POPG (55:45)/POPG and POPC:POPG:LPS
(60:20:20)/POPG.
doi:10.1371/journal.pone.0008385.g005
Figure 6. Fusion or hemifusion of membrane model systems
promoted by rBPI21. LUV labeled with 0.6% mol of RhB-PE and NBD-
PE were mixed with unlabeled liposomes to a final proportion of 1:4
and the energy transfer assay was evaluated in the presence of rBPI21
after 10 min of incubation. Bars represent the range from three
independent experiments. POPC (black circles); POPG (blue circles);
POPC:POPG 55:45 (orange circles); POPC:POPG 80:20 (green circles);
POPC:LPS 80:20 (red circles); POPC:POPG:LPS 60:20:20 (brown circles).
The differences in (hemi)fusion percentage for rBPI21 9 mM were
statistically significant between all data pairs, except POPC/POPC:LPS
(80:20).
doi:10.1371/journal.pone.0008385.g006
Figure 7. rBPI21-induced membrane leakage. Carboxyfluorescein
fluorescence increase measured 20 min after rBPI21 addition in POPC
(black circles), POPC:LPS 80:20 (red circles), POPC:POPG 80:20 (green
circles), POPC:POPG 55:45 (orange circles), POPC:POPG:LPS 60:20:20
(brown circles) and POPG (blue circles) liposomes. Bars represent the
range from at least two independent experiments. The differences in
leakage percentages for rBPI21 9 mM were statistically significant for the
following data pairs: POPC/POPC:LPS (80:20), POPC/POPC:POPG (80:20),
POPC/POPC:POPG (55:45), POPC/POPG, POPC/POPC:POPG:LPS
(60:20:20), POPC:LPS (80:20)/POPG:POPG (55:45), POPC:LPS (80:20)/
POPG, POPC:POPG (80:20)/POPC:POPG (55:45), POPC:POPG (80:20)/
POPG, POPC:POPG (55:45)/POPC:POPG:LPS (60:20:20) and POPC:
POPG:LPS (60:20:20)/POPG.
doi:10.1371/journal.pone.0008385.g007
LPS, PG Selectivity and rBPI21
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able to interact with negative charges of the LPS lipid A. The
result demonstrates that rBPI21 penetrates into the saccharide
region to interact with the lipid A. On the other hand, for systems
composed of POPC:POPG :LPS, in the presence of the peptide
the zeta-potential trend increases in a similar way as the POPC
with 20% of POPG. This behavior indicates a preference of the
peptide for POPG due to its accessible polar head.
Fusion of Liposomes Promoted by rBPI21
As aggregation occurs, there is a significant fusogenic activity
promoted by rBPI21, mainly on negatively charged liposomes
(Figure 6). The highest membrane fusion efficiency was observed
for pure POPG liposomes. The fusion efficiency increases with the
percentage of POPG content in the POPC:POPG mixtures. There
is no rBPI21-induced fusion of pure POPC liposomes. At variance
with what could be expected, when the negatively charged
molecules of LPS are added to liposomes the fusion efficiency does
not change. Therefore, rBPI21-induced fusion is limited to POPG-
containing membranes. The fusion behavior of membranes
composed of POPC with POPG and LPS (20% each) is similar
to liposomes made of POPC with 20% of POPG. The results
reinforce the idea that the peptide exerts higher membrane
destabilization in the presence of POPG and that the presence of
LPS does not cause an increase of the destabilization. This can be
due to its saccharide region, acting as a steric barrier for liposome-
liposome interaction. It is important to bear in mind that
Figure 8. Schematic representation of the proposed mechanism of action of rBPI21 protein. A) The protein interacts with LPS aggregates
promoting their aggregation, which allow LPS phagocytosis by innate immune cells and reduce LPS availability for its receptor. B) rBPI21 interacts
electrostatically with the LPS of the outer leaflet of outer membrane. This interaction disrupts the higher tight bond of the LPS, which allow the
peptide insertion and translocation to the outer membrane inner leaflet and to the intermembrane space. rBPI21 induces the fusion (or hemifusion) of
the inner leaflet of the outer membrane and the inner membrane (both rich in PG), following a process similar to the occurring at the Bayer junctions
[41]. These membrane fusion events promote an increased membrane permeability, culminating with the leakage of the bacterial content.
doi:10.1371/journal.pone.0008385.g008
LPS, PG Selectivity and rBPI21
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membrane hemifusion can also contribute to the parameter here
indicated as fusion efficiency.
rBPI21-Induced Carboxyfluorescein Leakage from
Liposomes
To complete the evaluation of the interaction of rBPI21 with
biomembrane model systems, the ability of the peptide to induce
the leakage of carboxyfluorescein from liposomes was measured
(Figure 7). The peptide exerts its higher effect on membranes
composed of negatively charged lipid. However, the effect is more
pronounced in membranes with higher content of POPG. As seen
before the electrostatic force acts as a main force for peptide
interaction, but there are other contributions for the effect.
Conclusion
We have shown that rBPI21, at 37uC, interact with negatively
charged LPS aggregates promoting their extensive aggregation.
This action can be important for the clearance of LPS from the
bloodstream, promoting its phagocytosis by macrophages. The
aggregation of LPS promoted by rBPI21 can also interfere with the
interaction of LPS with its receptor [30,31]. Thus, rBPI21 plays a
role against sepsis by neutralizing LPS toxicity.
Looking at the results obtained with biomembrane models
systems, one can conclude that the membrane destabilization
effects are only partially charge-dependent. The electrostatic force
plays a key role for the bactericidal action of the peptide as seen by
surface charge studies. When POPG is present both aggregation
and fusion occurs. rBPI21-induced membrane leakage is also more
pronounced for POPG-containing membranes. These results
explain the specificity of the peptide for bacterial membranes, in
comparison with mammalian membranes. For liposomes contain-
ing LPS, the membrane destabilization is more pronounced when
POPG is present. This result is consistent with the higher
susceptibility of deep rough bacteria when compared with rough
and smooth strains [40]. Deep rough bacteria have higher
phospholipid to LPS ratios in the outer leaflet of the outer
membranes, which contributes to a higher interaction with other
molecules. This can explain the higher susceptibility of deep rough
bacteria to antibiotics. In the absence of POPG, membranes of
POPC:LPS behave like POPC membranes in terms of rBPI21-
induced membrane fusion and extensive aggregation. The
saccharide region of LPS may act as a barrier against fusion and
aggregation, specially for strains with LPS with longer saccharide
components. However, leakage also occurs when LPS is present.
Our findings show that the peptide is able to interact with LPS
of the outer membrane and could translocate to the intermem-
brane space, enabling the interaction with the inner membrane,
where it exerts higher antimicrobial activity. Based on the results
obtained, a schematic representation of the mechanism of action
of rBPI21 is proposed (Figure 8). For LPS aggregates in the
bloodstream, rBIP21 interacts electrostatically with LPS promoting
their aggregation and neutralizing its toxicity (Figure 8A). Upon
interaction with Gram-negative bacteria, rBPI21 is able to bind to
the outer leaflet of the outer membrane, enriched in LPS, by
electrostatic forces. Afterwards, rBPI21 inserts into the LPS-rich
membrane [21] and moves to the space between the two bacterial
membranes. As both the inner leaflet of the outer membrane and
all the inner membrane are rich in PG, rBPI21 is able to induce the
binding between the two bacterial membranes and their fusion (or
hemifusion), following a process similar to what happens in the
Bayer junctions [41]. Based on this model and on our results we
propose that the fusion or hemifusion of the two bacterial
membranes, rich in PG, are the real cause of the changes in
permeability and leakage of bacteria content reported for rBPI21
and BPI (Figure 8B), instead of the simple interaction with LPS,
fully explaining at the molecular level both the mechanism of
microbicide action of rBPI21 and the naming of BPI as
‘‘bactericidal/permeability-increasing protein’’.
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